| | | | | | | | | | |
|
|
| Dockets Entered
On November 15, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
| 2003D-0290
|
| Compounding of Drugs for Use in Animals Compliance Policy Guide
|
|
|
| 2003P-0176
|
| Follow-Up Approval of Therapeutic Protein Products
|
|
|
| 2003P-0574
|
| Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
|
|
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
| 2004D-0377
|
| International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
|
|
|
| 2004F-0066
|
| Filing of Food Additive Petition (FAP 4A4754) Food Additives Permitted in Food on an Interim Basis or in Contact With Food Pending Additional Study; Mannitol
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
| 2004N-0355
|
| Scientific Considerations Related to Developing Follow-on Protein Products
|
|
|
| 2004P-0171
|
| Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
|
|
|
| 2004P-0231
|
| Deny approval of NDA 21-426 for Ominitrop 5.8 mg somatropin [ rDNA origin ] for injection, lyophilized powder and diluent with preservative
|
|
|
| 2004P-0349
|
| Action on Products containing added Mercury
|
|
|
| 2004V-0505
|
| Laser Light Show
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
| SF
9
|
| GCF-1
|
| Vol #:
|
| 444
|
|
|
| 2003D-0290
|
| Compounding of Drugs for Use in Animals Compliance Policy Guide
|
|
|
| C 11
|
| K and J Roach
|
| Vol #:
|
| 1
|
|
|
| 2003P-0176
|
| Follow-Up Approval of Therapeutic Protein Products
|
|
|
| C
2
|
| Barr Laboratories, Inc.
|
| Vol #:
|
| 2
|
|
|
| 2003P-0574
|
| Regulatory limit for Listeria monocytogenes in ready-to-eat foods that do not support its growth
|
|
|
| C
9
|
| WEBB Consulting, LLC
|
| Vol #:
|
| 2
|
|
|
| 2004D-0343
|
| Hospital Bed System Dimensional Guidance to Reduce Entrapment
|
|
|
| C
2
|
| Bed Safety Consulting, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004D-0377
|
| International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
|
|
|
|
|
|
| C
2
|
| GlaxoSmithKline
|
| Vol #:
|
| 1
|
|
|
| 2004F-0066
|
| Filing of Food Additive Petition (FAP 4A4754) Food Additives Permitted in Food on an Interim Basis or in Contact With Food Pending Additional Study; Mannitol
|
|
|
| BKG
1
Reference 2, 3
|
| Background
|
| Vol #:
|
| 1
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
| C
194
|
| Pet Food Institute
|
| Vol #:
|
| 23
|
|
|
| 2004N-0355
|
| Scientific Considerations Related to Developing Follow-on Protein Products
|
|
| | | | | | | | |
|
|
| C
3
|
| Amgen, Inc. (Amgen)
|
| Vol #:
|
| 1
|
|
|
| C
4
|
| Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| Vol #:
|
| 1
|
|
|
| C
5
|
| Sicor, Inc.
|
| Vol #:
|
| 1
|
|
|
| C
6
|
| Pfizer, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004P-0171
|
| Standards for 'Similarity' or 'Sameness' of Biotechnology-Derived Products
|
|
|
| C
5
|
| Barr Laboratories, Inc.
|
| Vol #:
|
| 1
|
|
|
| C
6
|
| Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| Vol #:
|
| 1
|
|
|
| 2004P-0231
|
| Deny approval of NDA 21-426 for Ominitrop 5.8 mg somatropin [ rDNA origin ] for injection, lyophilized powder and diluent with preservative
|
|
|
| C
2
|
| Barr Laboratories, Inc.
|
| Vol #:
|
| 1
|
|
|
| LET
1
|
| HFD-005 to Morgan Lewis & Bocklus LLP
|
| Vol #:
|
| 1
|
|
|
| 2004P-0349
|
| Action on Products containing added Mercury
|
|
|
| SUP
1
|
| Coalition for Mercury-free Drugs (CoMeD)
|
| Vol #:
|
| 1
|
|
|
| 2004V-0505
|
| Laser Light Show
|
|
|
| ACK
1
|
| HFA-305 to XEFX Productions
|
| Vol #:
|
| 1
|
|
|
| VAR
1
|
| XEFX Productions
|
| Vol #:
|
| 1
|
|